Medical technology company HeartBeam has secured two new patents from the US Patent and Trademark Office on its core vector electrocardiography (VECG) technology.
HeartBeam’s VECG technology gathers 3D signals of the heart, transforming them into a 12-lead ECG.
The first patent is ‘Mobile three-lead cardiac monitoring device and method for automated diagnostics’.
